Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide + methylprednisolone for peripheral blood stem cell mobilization in myeloma and indolent lymphoma
2005-002247-86Phase 4Terminated
- Sponsor
- Royal Devon University Healthcare NHS Foundation Trust
- Start
- Nov 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone, cyclophosphamide and lenograstim in multiple myeloma (MM) and lymphoma (2 arms), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoint: Day of first peripheral blood stem cell harvest. Started Nov 2005; status: terminated.
02
Drugs
methylprednisolonecyclophosphamidelenograstim
03
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on 2005-002247-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002247-86.